Immunodeficient patients with secondary lung disease benefit from combined chemotherapy
A team of researchers at the Medical College of Wisconsin and Children's Hospital of Wisconsin Research Institute defined a new treatment for a potentially fatal lung disease in patients with a primary immunodeficiency known ...
Aug 30, 2012
0
1